help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howie, A. F.
Right arrow Articles by Beckett, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howie, A. F.
Right arrow Articles by Beckett, G. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 6 2052-2058
Copyright © 1998 by The Endocrine Society


Original Studies

Identification of a 57-Kilodalton Selenoprotein in Human Thyrocytes as Thioredoxin Reductase and Evidence That Its Expression Is Regulated through the Calcium-Phosphoinositol Signaling Pathway1

A. Forbes Howie, John R. Arthur, Fergus Nicol, Simon W. Walker, Stuart G. Beech and Geoffrey J. Beckett

University Department of Clinical Biochemistry, The Royal Infirmary, Edinburgh, Scotland EH3 9YW; and The Rowett Research Institute (J.R.A., F.N.), Bucksburn, Aberdeen, Scotland AB21 9SB

Address all correspondence and requests for reprints to: Dr. G. J. Beckett, Department of Clinical Biochemistry, The Royal Infirmary, Edinburgh, Scotland EH3 9YW. E-mail: g.j.beckett{at}ed.ac.uk

Human thyrocytes incubated with the phorbol ester, phorbol 12-myristate 13-acetate (PMA; 10-5–10-8 mol/L) and the calcium ionophore A23187 (10-5–10-8 mol/L) showed a marked increase in the expression of a 57-kDa selenoprotein identified as thioredoxin reductase (TR). After the addition of A23187 with PMA, a significant induction in TR expression was observed after 6 h, with maximal induction occurring by 24 h. The addition of 8-bromo-cAMP (10-4 mol/L) or TSH (10 U/L) alone had no effect on TR expression, nor did these agents influence the induction of TR brought about by the addition of A23187 and PMA. These data show that the calcium-phosphoinositol second messenger cascade that controls hydrogen peroxide generation in the human thyrocyte is also an important stimulator of TR expression. The role of TR in the thyrocyte is unclear, but the selenoenzyme has a high capacity to detoxify compounds, such as hydrogen peroxide and lipid hydroperoxides, that are produced in high concentration during thyroid hormone synthesis.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Song, N. Driessens, M. Costa, X. De Deken, V. Detours, B. Corvilain, C. Maenhaut, F. Miot, J. Van Sande, M.-C. Many, et al.
Roles of Hydrogen Peroxide in Thyroid Physiology and Disease
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3764 - 3773.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. A. H. Cann
Hypothesis: dietary iodine intake in the etiology of cardiovascular disease.
J. Am. Coll. Nutr., February 1, 2006; 25(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev., December 1, 2005; 26(7): 944 - 984.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. J Beckett and J. R Arthur
Selenium and endocrine systems
J. Endocrinol., March 1, 2005; 184(3): 455 - 465.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zhang, V. Svehlikova, Y. Bao, A.F. Howie, G. J. Beckett, and G. Williamson
Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation
Carcinogenesis, March 1, 2003; 24(3): 497 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q.-A. Sun, Y. Wu, F. Zappacosta, K.-T. Jeang, B. J. Lee, D. L. Hatfield, and V. N. Gladyshev
Redox Regulation of Cell Signaling by Selenocysteine in Mammalian Thioredoxin Reductases
J. Biol. Chem., August 27, 1999; 274(35): 24522 - 24530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-K. Rundlof, M. Carlsten, and E. S. J. Arner
The Core Promoter of Human Thioredoxin Reductase 1. CLONING, TRANSCRIPTIONAL ACTIVITY, AND Oct-1, Sp1, AND Sp3 BINDING REVEAL A HOUSEKEEPING-TYPE PROMOTER FOR THE AU-RICH ELEMENT-REGULATED GENE
J. Biol. Chem., August 3, 2001; 276(32): 30542 - 30551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society